Investigational Site Number : 0360006
Wollongong, New South Wales 2500
1 studies enrolling now ยท 1 studies all time
What they study most
Plasma Cell Myeloma Refractory
Studies at this site
- Isatuximab in Combination With Novel Agents in RRMM - Master Protocol โ Recruiting now